Skip to main content
. 2012 Oct 30;5(1):215–222. doi: 10.3892/etm.2012.780

Table II.

Clinical characteristics of studied patients grouped by SGA.

Variables SGA-A SGA-B SGA-C Group comparison
Statistics P-value
Total (N) 126 103 23
Gender, male/female 78/48 64/39 13/10
Age, years 67.2±11.6 69.5±10.5 69.7±14.7 1.246 0.289
BMI, kg/m2 23.5±3.2 21.8±3.1 19.5±2.3 19.725 0.000
Duration of DM, years 11.6±8.3 13.1±8.8 9.9±6.5 1.732 0.179
Duration of DFU, daysa 55±87 73±101 138±292 3.312 0.039
HbA1c, % 8.7±2.1 8.5±2.2 9.6±2.9 1.227 0.302
Triglyceride, mmol/l 1.53±1.21 1.39±1.27 1.00±0.39 1.726 0.180
Total cholesterol, mmol/l 4.30±1.15 4.20±1.24 3.49±1.17 4.006 0.019
Hemoglobin, g/l 118.7±16.5 109.5±18.5 93.7±21.1 21.909 0.000
Total protein, g/l 66.1±7.0 65.1±5.8 59.5±8.5 9.591 0.000
Albumin, g/l 36.6±4.5 34.6±4.1 27.2±6.2 26.725 0.000
Creatinine, μmol/l 75.3±32.4 83.0±44.9 90.4±63.5 1.502 0.232
Log10UP-24hb 2.32±0.48 2.46±0.57 2.90±0.47 8.692 0.000
Log10UMA-24hb 1.74±0.60 1.87±0.76 2.20±0.58 3.038 0.050

Values are the mean ± SD or number (proportion). P-values are for the ANOVA across the three groups.

a

Values are for 192 Wagner grade 1–5 patients.

b

UP-24h, 24 h-urine protein; UMA-24h, 24 h-urine microalbumin. SGA, subjective global assessment; DM, diabetes mellitus; DFU, diabetic foot ulcer.